Clinical Trial Update: Sufficient Treatment of Peripheral Intervention by Cilostazol [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cilostazol for improving outcomes in peripheral intervention for peripheral artery disease due to arteriosclerosis obliterans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Pletal (cilostazol)

Snippet

Sponsor: Kansai Rosai Hospital | Conditions: Arteriosclerosis Obliterans | Phase 4 | Status: UNKNOWN